IPG
42
2
GS
58
5
FMC
22
2
GWW
51
3
PEP
36
3
MAR
60
3
QRVO
20
2
AVY
47
3
SNA
58
2
HAL
34
7
ES
29
3
SIG
55
3
TSCO
48
5
JNJ
39
4
IVZ
48
3
ADSK
63
2
MTB
40
2
VLO
28
2
PFE
33
-2
MAT
43
2
IPG
42
2
GS
58
5
FMC
22
2
GWW
51
3
PEP
36
3
MAR
60
3
QRVO
20
2
AVY
47
3
SNA
58
2
HAL
34
7
ES
29
3
SIG
55
3
TSCO
48
5
JNJ
39
4
IVZ
48
3
ADSK
63
2
MTB
40
2
VLO
28
2
PFE
33
-2
MAT
43
2
Financhill
Back

Windtree Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
16

WINT
Windtree Therapeutics

Last Price:
$0.31
Seasonality Move:
-9.01%
Sell
31

CATX
Perspective Therapeutics

Last Price:
$3.25
Seasonality Move:
41.25%
Sell
16
Windtree Therapeutics (WINT) is a Sell

Is Windtree Therapeutics a Buy, Sell or Hold?

  • The current Windtree Therapeutics [WINT] share price is $0.30. The Score for WINT is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
  • WINT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
31
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.25. The Score for CATX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

WINT Stock Price Chart

What is Windtree Therapeutics's stock price today?

  • The Windtree Therapeutics share price today is $0.30
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.25
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

WINT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.11 Sell
Relative Strength Index (14 RSI): 27.61 Sell
Chaikin Money Flow: -215445 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.34 - 0.52) Sell
Bollinger Bands (100): (-0.73 - 7.15) Sell

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.22 Sell
Relative Strength Index (14 RSI): 28.01 Sell
Chaikin Money Flow: 344055 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.89 - 4.69) Sell
Bollinger Bands (100): (6.4 - 14.96) Sell

WINT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.35 Sell
20-day SMA: 0.41 Sell
50-day SMA: 0.57 Sell
200-day SMA: 4.06 Sell
8-day EMA: 0.34 Sell
20-day EMA: 0.41 Sell
50-day EMA: 0.95 Sell
200-day EMA: 8.72 Sell

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.14 Buy
20-day SMA: 3.58 Sell
50-day SMA: 7.6 Sell
200-day SMA: 12.12 Sell
8-day EMA: 3.19 Buy
20-day EMA: 4.02 Sell
50-day EMA: 6.68 Sell
200-day EMA: 9.88 Sell

Windtree Therapeutics Earnings Growth & WINT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $89.20 per share, and an increase next year of $2.80 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

Windtree Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):